Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

Autor: Chanson N; AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France., Galvagni A; AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France., Ramos-Casals M; Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain.; Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Ruiz JI; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pm Suijkerbuijk K; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, the Netherlands., Benesova K; Department of Internal Medicine and Rheumatology, Universitätsklinikum Heidelberg, Germany., Kerschen P; Service de Neurologie, Centre Hospitalier de Luxembourg, Luxembourg-Ville, Luxembourg., Karam JD; Internal Medicine and RECIF, CHU Amiens Picardie, Amiens, France., Belkhir R; AP-HP, Université Paris Saclay, department of rheumatology, Bicêtre Hospital, Le Kremlin Bicêtre, France., Outh R; Service de Médecine interne et générale, Centre Hospitalier de Perpignan, Perpignan, France., Closs-Prophette F; Médecine Polyvalente, Centre Hospitalier du Mans, France., Morillo JSG; Department of Internal Medicine, Universitario Hospital Virgen Del Rocio, Sevilla, Spain., Robles-Marhuenda Á; Internal Medicine Department, Hospital universitario La Paz, Madrid, Spain., Michot JM; Departement D'Innovation Therapeutique et D'Essais Precoces, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Voisin AL; Departement D'Innovation Therapeutique et D'Essais Precoces, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Messayke S; Departement D'Innovation Therapeutique et D'Essais Precoces, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Laparra A; DIOPP, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Robert C; Department of Dermatology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, F-94805, France., Suarez-Almazor M; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mariette X; AP-HP, Université Paris Saclay, department of rheumatology, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT, UMR1184, Department IBFJ, Le Kremlin-Bicêtre, France., Lambotte O; AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT, UMR1184, Department IBFJ, Le Kremlin-Bicêtre, France.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Dec 23. Date of Electronic Publication: 2024 Dec 23.